Respirology
Differentiating Causes of Dyspnea and Cough – Could your Patient have Interstitial Lung Disease?
Interstitial lung disease (ILD) is a group of pulmonary conditions that are characterized by diffuse parenchymal lung infiltration.This is caused by lung inflammation and/or lung fibrosis. Although less common than other respiratory conditions, ILD can be associated with significant mortality risk, higher than many different types of cancer. There is also a lack of public awareness of this condition. With treatments available to reduce ILD progression and mortality risk, time lost before diagnosis translates to lung lost. This program is designed to help provide the primary care clinician with guidance regarding when to suspect ILD and their role in the assessment and referral of these patients.
DURATION
1 hr
PROFESSION
Physician
# OF CREDITS
1.0
ACCREDITATION
Mainpro+
EXPIRY DATE
2025-04-23
Interstitial lung disease (ILD) is a large group of lung diseases affecting the tissue and space around the alveoli of the lungs, which cause progressive scarring of lung tissue through inflammation and/or fibrosis. This diminishes the lung’s capacity for alveolar gas diffusion. ILD is associated with significant morbidity and mortality. Although timely diagnosis is important to delay disease progression and prolong survival, there is commonly a delay of 7 months to more than 5 years from the onset of symptoms prior to diagnosis. Primary care clinicians play a crucial role in the initial assessment and referral of patients with suspected ILD. This program will provide the clinician with a quick review of when to suspect ILD, the initial testing and how to optimize referral to Respirology for a timely diagnosis.
This program has received financial support from Boehringer Ingelheim in the form of an unrestricted educational grant.
Faculty
Nooreen Mann, MD, FRCPC
Jessica Chan, MD, CCFP
Jeffrey Habert, MD, CCFP, FCFP
Bruno Bernucci, MD, CCFP
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Explain the prevalence and impact of interstitial lung disease (ILD)
- Describe the barriers to identifying patients with ILD
- Determine the initial assessment of a patient with suspected ILD, including patient history, examination, and diagnostic tests
- Differentiate between ILD and other common conditions with similar clinical presentations
- Determine the role of primary care physicians in patients with IPF prescribed antifibrotic therapy
Accreditation
This self-learning program has been certified by the College of Family Physicians of Canada for up to 1.0 Mainpro+ credits.
Cert+ Program ID#: 202316.